{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:51:02Z","timestamp":1785527462891,"version":"3.56.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R16GM153648"],"award-info":[{"award-number":["R16GM153648"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Institute","award":["R03CA293129"],"award-info":[{"award-number":["R03CA293129"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Accurate measurement of antigen presentation is essential for understanding immune responses to infections and tumors. However, current methods are cumbersome, time-consuming, and rely on known peptide sequences and antibodies, leading to unstable antigen presentation, antigen loss during processing and editing, and inconsistent results. We developed a novel, cost-effective method for examining antigen presentation using Click chemistry, which utilizes a bioorthogonal reaction between azides and alkynes\/cyclooctenes. Antigens were pre-labeled with azides or alkynes to facilitate their uptake by antigen-presenting cells (APCs). Their presentation was subsequently detected using fluorophore-conjugated dibenzocyclooctyne or azide. The study involved three types of APCs, mouse macrophages (RAW264.7), mouse dendritic cells (DC2.4), and mouse primary bone marrow derived dendritic cells (BMDCs), and three categories of antigens: BSA, bacteria, and tumor antigens. Antigen presentation was measured and validated through multiple analytic techniques, including a fluorescent plate reader, flow cytometry, and ELISA. We showed efficient and stable presentation of antigens on the surface of all RAW264.7, DC2.4 and BMDCs. Antigens labeled using Click chemistry showed enhanced stability within the phagolysosomes of APCs. Notably, antigens labeled throughout the peptide sequence using azidohomoalanine (AHA) exhibited superior presentation on MHC class II compared to antigens labeled only at the N-terminus. Furthermore, this method preserved the natural antigen editing process, enabling the selection of high-affinity antigens for MHC presentation. This novel antigen presentation assay offers key advantages over existing methods, including faster processing, cost-effectiveness, stable antigen presentation, and reliable detection signals. When paired with mass spectrometry, it can identify stably presented tumor peptides, offering potential targets for immunotherapy development.<\/jats:p>","DOI":"10.1038\/s41598-025-13997-y","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:21:19Z","timestamp":1758885679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a novel assay for antigen presentation measurement"],"prefix":"10.1038","volume":"15","author":[{"given":"Mei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falak Harshit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Esteban","family":"Araneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Hammett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derick","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Hui E.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"3","key":"13997_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/cancers15030729","volume":"15","author":"C Shi","year":"2023","unstructured":"Shi, C. et al. ultifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms. Cancers (Basel) 15(3), 729 (2023).","journal-title":"Cancers (Basel)"},{"issue":"6","key":"13997_CR2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ebiom.2015.05.022","volume":"2","author":"DS Wishart","year":"2015","unstructured":"Wishart, D. S. Is cancer a genetic disease or a metabolic disease? EBioMedicine 2 (6), 478\u2013479 (2015).","journal-title":"EBioMedicine"},{"issue":"1","key":"13997_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13073-017-0408-2","volume":"9","author":"RJ Hartmaier","year":"2017","unstructured":"Hartmaier, R. J. et al. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies. Genome. Med. 9(1), 16 (2017).","journal-title":"Genome. Med."},{"issue":"1","key":"13997_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12943-024-02141-5","volume":"23","author":"R Yang","year":"2024","unstructured":"Yang, R. & Cui, J. Advances and applications of RNA vaccines in tumor treatment. Mol. Cancer. 23 (1), 226 (2024).","journal-title":"Mol. Cancer"},{"issue":"1","key":"13997_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13073-024-01281-z","volume":"16","author":"V Trivedi","year":"2024","unstructured":"Trivedi, V. et al. mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors. Genome. Med. 16(1), 17 (2024).","journal-title":"Genome. Med."},{"issue":"1","key":"13997_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10238-024-01436-7","volume":"24","author":"DW Wu","year":"2024","unstructured":"Wu, D. W. et al. Personalized neoantigen cancer vaccines: current progression, challenges and a bright future. Clin. Experimental Med. 24 (1), 229 (2024).","journal-title":"Clin. Experimental Med."},{"issue":"1","key":"13997_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13045-021-01209-9","volume":"14","author":"J Lemoine","year":"2021","unstructured":"Lemoine, J., Ruella, M. & Houot, R. Born to survive: how cancer cells resist CAR T cell therapy. J. Hematol. Oncol. 14 (1), 199 (2021).","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"13997_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrclinonc.2017.49","volume":"14","author":"AF Daniyan","year":"2017","unstructured":"Daniyan, A. F. & Brentjens, R. J. Hiding in plain sight: immune escape in the era of targeted T-cell-based immunotherapies. Nat. Reviews Clin. Oncol. 14 (6), 333\u2013334 (2017).","journal-title":"Nat. Reviews Clin. Oncol."},{"issue":"6","key":"13997_CR9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00262-018-2131-2","volume":"67","author":"L Cai","year":"2018","unstructured":"Cai, L. et al. Defective HLA class I antigen processing machinery in cancer. Cancer Immunol. Immunother. 67 (6), 999\u20131009 (2018).","journal-title":"Cancer Immunol. Immunother."},{"key":"13997_CR10","first-page":"360","volume-title":"Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis","author":"SJ Gaudino","year":"2019","unstructured":"Gaudino, S. J. & Kumar, P. Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis.\u00a0Front Immunol. 10, 360 (2019)."},{"issue":"2","key":"13997_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2567.2003.01738.x","volume":"110","author":"EW Hewitt","year":"2003","unstructured":"Hewitt, E. W. The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110 (2), 163\u2013169 (2003).","journal-title":"Immunology"},{"issue":"2","key":"13997_CR12","doi-asserted-by":"publisher","first-page":"e2416992122","DOI":"10.1073\/pnas.2416992122","volume":"122","author":"Y Sun","year":"2025","unstructured":"Sun, Y. et al. CryoEM structure of an MHC-I\/TAPBPR peptide-bound intermediate reveals the mechanism of antigen proofreading. Proc. Natl. Acad. Sci. U S A. 122 (2), e2416992122 (2025).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"13997_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nri3818","volume":"15","author":"PA Roche","year":"2015","unstructured":"Roche, P. A. & Furuta, K. The Ins and outs of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 15 (4), 203\u2013216 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"13997_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2019.12.005","volume":"64","author":"JD Colbert","year":"2020","unstructured":"Colbert, J. D., Cruz, F. M. & Rock, K. L. Cross-presentation of exogenous antigens on MHC I molecules. Curr. Opin. Immunol. 64, 1\u20138 (2020).","journal-title":"Curr. Opin. Immunol."},{"issue":"5195","key":"13997_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1126\/science.7809629","volume":"267","author":"M Kovacsovics-Bankowski","year":"1995","unstructured":"Kovacsovics-Bankowski, M. & Rock, K. L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267 (5195), 243\u2013246 (1995).","journal-title":"Science"},{"issue":"2","key":"13997_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.immuni.2004.07.004","volume":"21","author":"L Shen","year":"2004","unstructured":"Shen, L. et al. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 21 (2), 155\u2013165 (2004).","journal-title":"Immunity"},{"issue":"6","key":"13997_CR17","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.4049\/jimmunol.0803458","volume":"182","author":"VL Crotzer","year":"2009","unstructured":"Crotzer, V. L. & Blum, J. S. Autophagy and its role in MHC-mediated antigen presentation. J. Immunol. 182 (6), 3335\u20133341 (2009).","journal-title":"J. Immunol."},{"issue":"17","key":"13997_CR18","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.1158\/0008-5472.CAN-08-0161","volume":"68","author":"Y Li","year":"2008","unstructured":"Li, Y. et al. Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res. 68 (17), 6889\u20136895 (2008).","journal-title":"Cancer Res."},{"key":"13997_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.coi.2016.03.007","volume":"40","author":"AW Purcell","year":"2016","unstructured":"Purcell, A. W., Croft, N. P. & Tscharke, D. C. Immunology by numbers: quantitation of antigen presentation completes the quantitative milieu of systems immunology! Curr. Opin. Immunol. 40, 88\u201395 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"13997_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.coi.2013.11.006","volume":"26","author":"N Shastri","year":"2014","unstructured":"Shastri, N. et al. Monitoring peptide processing for MHC class I molecules in the Endoplasmic reticulum. Curr. Opin. Immunol. 26, 123\u2013127 (2014).","journal-title":"Curr. Opin. Immunol."},{"issue":"12","key":"13997_CR21","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/ni859","volume":"3","author":"T Saric","year":"2002","unstructured":"Saric, T. et al. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, Trims precursors to MHC class I-presented peptides. Nat. Immunol. 3 (12), 1169\u20131176 (2002).","journal-title":"Nat. Immunol."},{"issue":"1","key":"13997_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/ni1286","volume":"7","author":"GE Hammer","year":"2006","unstructured":"Hammer, G. E. et al. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat. Immunol. 7 (1), 103\u2013112 (2006).","journal-title":"Nat. Immunol."},{"issue":"6906","key":"13997_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature01074","volume":"419","author":"T Serwold","year":"2002","unstructured":"Serwold, T. et al. ERAAP customizes peptides for MHC class I molecules in the Endoplasmic reticulum. Nature 419 (6906), 480\u2013483 (2002).","journal-title":"Nature"},{"issue":"9","key":"13997_CR24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1182\/bloodadvances.2018030452","volume":"3","author":"W Jankowski","year":"2019","unstructured":"Jankowski, W. et al. Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products. Blood Adv. 3 (9), 1429\u20131440 (2019).","journal-title":"Blood Adv."},{"issue":"11","key":"13997_CR25","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","volume":"40","author":"HC Kolb","year":"2001","unstructured":"Kolb, H. C., Finn, M. G. & Sharpless, K. B. Click chemistry: diverse chemical function from a few good reactions. Angew Chem. Int. Ed. Engl. 40 (11), 2004\u20132021 (2001).","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"46","key":"13997_CR26","doi-asserted-by":"publisher","first-page":"15046","DOI":"10.1021\/ja044996f","volume":"126","author":"NJ Agard","year":"2004","unstructured":"Agard, N. J., Prescher, J. A. & Bertozzi, C. R. A Strain-Promoted [3\u2009+\u20092] Azide\u2009\u2013\u2009Alkyne cycloaddition for covalent modification of biomolecules in living systems. J. Am. Chem. Soc. 126 (46), 15046\u201315047 (2004).","journal-title":"J. Am. Chem. Soc."},{"key":"13997_CR27","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/qsar.200740086","volume":"26","author":"JM Baskin","year":"2007","unstructured":"Baskin, J. M. & Bertozzi, C. R. Bioorthogonal click chemistry: covalent labeling in living systems. QSAR Comb. Sci. 26, 1211\u20131219 (2007).","journal-title":"QSAR Comb. Sci."},{"issue":"11","key":"13997_CR28","doi-asserted-by":"publisher","first-page":"7383","DOI":"10.1039\/D4RA00494A","volume":"14","author":"Mehak","year":"2024","unstructured":"Mehak et al. Clicking in harmony: exploring the bio-orthogonal overlap in click chemistry. RSC Adv. 14 (11), 7383\u20137413 (2024).","journal-title":"RSC Adv."},{"issue":"24","key":"13997_CR29","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMcibr2213596","volume":"387","author":"BM Zeglis","year":"2022","unstructured":"Zeglis, B. M. & Lewis, J. S. Click here for better chemistry. N Engl. J. Med. 387 (24), 2291\u20132293 (2022).","journal-title":"N Engl. J. Med."},{"key":"13997_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/B978-0-12-818731-9.00029-X","volume-title":"Encyclopedia of Infection and Immunity","author":"PP Nesmiyanov","year":"2022","unstructured":"Nesmiyanov, P. P. & Rezaei, N. Antigen presentation and major histocompatibility complex. Encyclopedia of Infection and Immunity. 1, 90\u201398 (2022)."},{"issue":"6","key":"13997_CR31","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1021\/acs.jproteome.9b00874","volume":"19","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B. et al. Improved prediction of MHC II antigen presentation through integration and motif Deconvolution of mass spectrometry MHC eluted ligand data. J. Proteome Res. 19 (6), 2304\u20132315 (2020).","journal-title":"J. Proteome Res."},{"key":"13997_CR32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","volume":"8","author":"M Wieczorek","year":"2017","unstructured":"Wieczorek, M. et al. Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front. Immunol. 8, 292 (2017).","journal-title":"Front. Immunol."},{"issue":"28","key":"13997_CR33","doi-asserted-by":"publisher","first-page":"23389","DOI":"10.1021\/acsami.7b05262","volume":"9","author":"HJ Lee","year":"2017","unstructured":"Lee, H. J. et al. Tethering growth factors to collagen surfaces using Copper-Free click chemistry: surface characterization and in vitro biological response. ACS Appl. Mater. Interfaces. 9 (28), 23389\u201323399 (2017).","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"13997_CR34","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1038\/s41467-022-30654-4","volume":"13","author":"CJ Greene","year":"2022","unstructured":"Greene, C. J. et al. Macrophages disseminate pathogen associated molecular patterns through the direct extracellular release of the soluble content of their phagolysosomes. Nat. Commun. 13 (1), 3072 (2022).","journal-title":"Nat. Commun."},{"issue":"1","key":"13997_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/0471143030.cb0711s56","volume":"56","author":"S Tom Dieck","year":"2012","unstructured":"Tom Dieck, S. et al. Metabolic labeling with noncanonical amino acids and visualization by chemoselective fluorescent tagging. Curr. Protoc. Cell. Biol. 56(1), 7\u201311 (2012).","journal-title":"Curr. Protoc. Cell. Biol."},{"issue":"1","key":"13997_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1073\/pnas.012583299","volume":"99","author":"KL Kiick","year":"2002","unstructured":"Kiick, K. L. et al. Incorporation of Azides into Recombinant proteins for chemoselective modification by the Staudinger ligation. Proc. Natl. Acad. Sci. U S A. 99 (1), 19\u201324 (2002).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"7","key":"13997_CR37","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/nn.2580","volume":"13","author":"DC Dieterich","year":"2010","unstructured":"Dieterich, D. C. et al. In situ visualization and dynamics of newly synthesized proteins in rat hippocampal neurons. Nat. Neurosci. 13 (7), 897\u2013905 (2010).","journal-title":"Nat. Neurosci."},{"issue":"3","key":"13997_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2332\/allergolint.08-OA-0081","volume":"58","author":"F Sato","year":"2009","unstructured":"Sato, F. et al. Effect of BSA antigen sensitization during the acute phase of influenza A viral infection on CD11c\u2009+\u2009pulmonary antigen presenting cells. Allergol. Int. 58 (3), 445\u2013454 (2009).","journal-title":"Allergol. Int."},{"key":"13997_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24966\/CIIT-8844\/1000072","volume":"8","author":"W Chen","year":"2022","unstructured":"Chen, W. Supplemental fetal calf serum in T cell culture media expands bovine serum Albumin-Specific human CD4\u2009+\u2009T cells. Clin. Immunol. Immunotherapy. 8, 1\u201311 (2022).","journal-title":"Clin. Immunol. Immunotherapy"},{"issue":"5","key":"13997_CR40","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0171-2985(82)80060-0","volume":"163","author":"M Ohta","year":"1982","unstructured":"Ohta, M., Nakashima, I. & Kato, N. Adjuvant action of bacterial lipopolysaccharide in induction of delayed-type hypersensitivity to protein antigens. II. Relationships of intensity of the action to that of other immunological activities. Immunobiology 163 (5), 460\u2013469 (1982).","journal-title":"Immunobiology"},{"issue":"1","key":"13997_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.coi.2012.10.001","volume":"25","author":"M Weimershaus","year":"2013","unstructured":"Weimershaus, M. et al. Peptidases trimming MHC class I ligands. Curr. Opin. Immunol. 25 (1), 90\u201396 (2013).","journal-title":"Curr. Opin. Immunol."},{"issue":"11","key":"13997_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0966-842X(96)10067-6","volume":"4","author":"C Cheers","year":"1996","unstructured":"Cheers, C. & Zhan, Y. How do macrophages distinguish the living from the dead? Trends Microbiol. 4 (11), 453\u2013455 (1996).","journal-title":"Trends Microbiol."},{"issue":"10","key":"13997_CR43","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1128\/iai.62.10.4396-4403.1994","volume":"62","author":"I Kawamura","year":"1994","unstructured":"Kawamura, I. et al. Antigen provoking gamma interferon production in response to Mycobacterium Bovis BCG and functional difference in T-cell responses to this antigen between viable and killed BCG-immunized mice. Infect. Immun. 62 (10), 4396\u20134403 (1994).","journal-title":"Infect. Immun."},{"issue":"3","key":"13997_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1001\/archpedi.1965.02090020234007","volume":"109","author":"LW RAUH","year":"1965","unstructured":"RAUH, L. W. Measles immunization with killed virus vaccine: serum antibody titers and experience with exposure to measles epidemic. Am. J. Dis. Child. 109 (3), 232\u2013237 (1965).","journal-title":"Am. J. Dis. Child."},{"issue":"5547","key":"13997_CR45","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1126\/science.1064571","volume":"294","author":"G Lauvau","year":"2001","unstructured":"Lauvau, G. et al. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294 (5547), 1735\u20131739 (2001).","journal-title":"Science"},{"issue":"10","key":"13997_CR46","doi-asserted-by":"publisher","first-page":"12599","DOI":"10.3390\/molecules181012599","volume":"18","author":"Y Yang","year":"2013","unstructured":"Yang, Y., Yang, X. & Verhelst, S. H. L. Comparative analysis of click chemistry mediated Activity-Based protein profiling in cell lysates. Molecules 18 (10), 12599\u201312608 (2013).","journal-title":"Molecules"},{"key":"13997_CR47","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1146\/annurev.immunol.22.012703.104538","volume":"23","author":"ES Trombetta","year":"2005","unstructured":"Trombetta, E. S. & Mellman, I. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23, 975\u20131028 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"13997_CR48","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3389\/fimmu.2020.01100","volume":"11","author":"J Zepeda-Cervantes","year":"2020","unstructured":"Zepeda-Cervantes, J., Ram\u00edrez-Jarqu\u00edn, J. O. & Vaca, L. Interaction between Virus-Like particles (VLPs) and pattern recognition receptors (PRRs) from dendritic cells (DCs): toward better engineering of VLPs. Front. Immunol. 11, 1100 (2020).","journal-title":"Front. Immunol."},{"key":"13997_CR49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163449","author":"C Lee-Chang","year":"2023","unstructured":"Lee-Chang, C. & Lesniak, M. S. Next-generation antigen-presenting cell immune therapeutics for gliomas. J. Clin. Invest.\u00a0133(3), e163449\u00a0(2023).","journal-title":"J. Clin. Invest."},{"issue":"4","key":"13997_CR50","first-page":"245","volume":"2","author":"LJ Stern","year":"1994","unstructured":"Stern, L. J. & Wiley, D. C. Antigenic peptide binding by class I and class II histocompatibility proteins. Behring Inst. Mitt 2(4), 245\u2013251 (1994).","journal-title":"Behring Inst. Mitt"},{"issue":"2","key":"13997_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13223-018-0278-1","volume":"14","author":"JS Marshall","year":"2018","unstructured":"Marshall, J. S. et al. An introduction to immunology and immunopathology. Allergy Asthma Clin. Immunol. 14 (2), 49 (2018).","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"5824","key":"13997_CR52","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1137971","volume":"316","author":"S Burgdorf","year":"2007","unstructured":"Burgdorf, S. et al. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316 (5824), 612\u2013616 (2007).","journal-title":"Science"},{"issue":"16","key":"13997_CR53","doi-asserted-by":"publisher","first-page":"e99266","DOI":"10.15252\/embj.201899266","volume":"38","author":"D Sengupta","year":"2019","unstructured":"Sengupta, D. et al. Proteasomal degradation within endocytic organelles mediates antigen cross-presentation. Embo J. 38 (16), e99266 (2019).","journal-title":"Embo J."},{"issue":"18","key":"13997_CR54","doi-asserted-by":"publisher","first-page":"10326","DOI":"10.1073\/pnas.96.18.10326","volume":"96","author":"M Gromm\u00e9","year":"1999","unstructured":"Gromm\u00e9, M. et al. Recycling MHC class I molecules and endosomal peptide loading. Proc. Natl. Acad. Sci. U S A. 96 (18), 10326\u201310331 (1999).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"13997_CR55","first-page":"1276","volume":"11","author":"EM Muntjewerff","year":"2020","unstructured":"Muntjewerff, E. M., Meesters, L. D. & van den Bogaart, G. Antigen cross-presentation macrophages. Front. Immunol. 11: 1276. (2020).","journal-title":"Antigen Cross-Presentation Macrophages Front. Immunol."},{"issue":"7","key":"13997_CR56","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/cancers12071760","volume":"12","author":"AM Cornel","year":"2020","unstructured":"Cornel, A. M., Mimpen, I. L. & Nierkens, S. MHC class I downregulation in cancer: underlying mechanisms and potential targets for cancer immunotherapy. Cancers 12 (7), 1760 (2020).","journal-title":"Cancers"},{"key":"13997_CR57","doi-asserted-by":"publisher","first-page":"636568","DOI":"10.3389\/fimmu.2021.636568","volume":"12","author":"K Dhatchinamoorthy","year":"2021","unstructured":"Dhatchinamoorthy, K., Colbert, J. D. & Rock, K. L. Cancer immune evasion through loss of MHC class I antigen presentation. Front. Immunol. 12, 636568 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"13997_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40610-023-00157-2","volume":"10","author":"A Caner","year":"2024","unstructured":"Caner, A. Immune escape mechanism of cancer. Curr. Mol. Biology Rep. 10 (1), 9\u201319 (2024).","journal-title":"Curr. Mol. Biology Rep."},{"issue":"2","key":"13997_CR59","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1142\/S0219720006002016","volume":"4","author":"NS Bogatyreva","year":"2006","unstructured":"Bogatyreva, N. S., Finkelstein, A. V. & Galzitskaya, O. V. Trend of amino acid composition of proteins of different taxa. J. Bioinform Comput. Biol. 4 (2), 597\u2013608 (2006).","journal-title":"J. Bioinform Comput. Biol."},{"issue":"8","key":"13997_CR60","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nri3254","volume":"12","author":"OP Joffre","year":"2012","unstructured":"Joffre, O. P. et al. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12 (8), 557\u2013569 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"13997_CR61","doi-asserted-by":"crossref","unstructured":"Wieczorek, M. et al. Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front. Immunol. 8, 292 (2017).","DOI":"10.3389\/fimmu.2017.00292"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13997-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13997-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13997-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:07:18Z","timestamp":1758888438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13997-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13997"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13997-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33168"}}